APOTEX INC, — Escitalopram Importer Profile
Pharmaceutical Importer · #19 buyer for Escitalopram · $1.3M import value · 42 shipments · CANADA · DGFT Verified
APOTEX INC, is the #19 importer of Escitalopram from India with $1.3M in import value and 42 verified shipments. APOTEX INC, holds a 0.7% market share in Escitalopram imports based in CANADA. The company sources from 1 verified supplier across 26 formulations shipped to 1 country. Overall, APOTEX INC, imports 14 pharmaceutical products worth $40.9M across 7 therapeutic categories.
APOTEX INC, — Escitalopram Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Escitalopram to APOTEX INC,?
Verified from 42 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| APOTEX RESEARCH PRIVATE LIMITED | $1.3M | 42 | 100.0% |
APOTEX INC, sources Escitalopram from 1 verified Indian supplier based on 42 customs records. The primary supplier is APOTEX RESEARCH PRIVATE LIMITED accounting for 100.0% of imports.
How Does APOTEX INC, Compare to Nearest Escitalopram Importers?
Buyers ranked immediately above and below #19 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $1.4M | 28 | $50.0K |
| 15 | SANDOZ PTY LTD, | AUSTRALIA | $1.4M | 27 | $50.0K |
| 19 | APOTEX INC, ★ | CANADA | $1.3M | 42 | $32.0K |
| 20 | MICRO LABS GMBH | GERMANY | $1.3M | 49 | $26.8K |
APOTEX INC, ranks #19 among 628 Escitalopram importers from India. Average shipment value of $32.0K compared to the market average of $53.1K. The closest competitors by value are AUROLOGISTICS LLC AUROBINDO PHARM and SANDOZ PTY LTD,.
Where Does APOTEX INC, Import Escitalopram To?
Destination countries from 42 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.3M | 42 | 100.0% |
APOTEX INC, imports Escitalopram to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.3M.
What Escitalopram Formulations Does APOTEX INC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| APO-ESCITALOPRAM FCT 10MG 100 BTL 51667/ | $201.3K | 5 |
| APO-ESCITALOPRAM FCT 20MG 100 BTL 51668/ | $175.0K | 5 |
| APO-ESCITALOPRAM FCT 10MG 100 BTL 51667/ 771313189941 -VJ6263 | $100.0K | 2 |
| APO-ESCITALOPRAM FCT 20MG 100 BTL 51668/ 771313189958 -VJ6275 | $76.7K | 2 |
| APO-ESCITALOPRAM FCT 10MG 100 BTL 51667 | $72.0K | 2 |
| APO-ESCITALOPRAM FCT 10 MG 100 BTL 51667 | $63.7K | 2 |
| APO-ESCITALOPRAM FCT 10MG 100 BTL 51667/ 771313189941-TY4085 | $50.0K | 1 |
| APO-ESCITALOPRAM FCT 10MG 100 BTL 51667/ 771313189941 BATCH LOT NO-TZ9626 | $50.0K | 1 |
| APO-ESCITALOPRAM FCT 10MG 100 BTL 51667/ 771313189941 BATCH LOT NO-VA9030 | $46.6K | 1 |
| APO-ESCITALOPRAM FCT 20MG 100 BTL 51668/ 771313189958-TY4088 | $39.1K | 1 |
APOTEX INC, imports 26 distinct Escitalopram formulations from India. The top formulation is APO-ESCITALOPRAM FCT 10MG 100 BTL 51667/ with 5 shipments worth $201.3K.
Regulatory Requirements: Importing Escitalopram into Canada
What APOTEX INC, and other importers must comply with to import Escitalopram from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Escitalopram
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Escitalopram from India and How Much Does APOTEX INC, Import?
India exported $33.3M worth of Escitalopram through 5,457 shipments from 231 suppliers to 95 countries, serving 628 buyers globally. APOTEX INC, imports $1.3M of this total, accounting for 0.7% of India's Escitalopram exports with 42 shipments from CANADA. This is verified from 42 customs shipment records covering 26 distinct formulations.
What Is the Average Order Value for APOTEX INC,'s Escitalopram Imports?
APOTEX INC,'s average Escitalopram order value is $30.2K per consignment, based on 42 shipments totaling $1.3M. APOTEX INC, is based in CANADA and ranks #19 among all Escitalopram importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Escitalopram to APOTEX INC,?
APOTEX INC, sources Escitalopram from 1 verified Indian supplier: APOTEX RESEARCH PRIVATE LIMITED ($1.3M, 100.0%). This is based on 42 customs records.
How Does APOTEX INC, Compare to Other Escitalopram Importers?
APOTEX INC, ranks #19 among 628 Escitalopram importers from India with a 0.7% market share. The top 3 importers are TORRENT PHARMA INC ($4.2M), LEK S.A. ($4.1M), CIPLA MAROC ($3.5M). APOTEX INC, processed 42 shipments from CANADA.
About APOTEX INC,
APOTEX INC, imports 14 products worth $40.9M. Beyond Escitalopram, top products include Apixaban, Fluticasone, Atorvastatin, Amino, Acetaminophen. View the complete APOTEX INC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Escitalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Escitalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX INC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX INC,'s capped import value divided by total capped export value for Escitalopram across all Indian exporters.
- 5.Verified Records: This page is backed by 42 individual customs records matching APOTEX INC, importing Escitalopram, covering 26 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 95+ countries, 628+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Escitalopram Import Data for APOTEX INC,
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX INC,'s Escitalopram imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX INC,
Full Company Profile →
14 products · $40.9M total trade · 7 categories
APOTEX INC, × Escitalopram
Verified from customs records
Company Overview
Top Products by APOTEX INC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX INC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Escitalopram. For current order-level data, contact TransData Nexus.